Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02079714 · ClinicalTrials.gov registry record
Streamlining Trauma Research Evaluation With Advanced Measurement
A clinical trial, sponsored by Major Extremity Trauma Research Consortium.
- Completed
- Registry status
- 1,065
- Enrollment target
NCT02079714: Completed study, sponsored by Major Extremity Trauma Research Consortium.
NCT02079714 is a clinical trial that has completed, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 1,065 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02079714 has completed, sponsored by Major Extremity Trauma Research Consortium.
- COMPLETED
- Registry status
- 1,065 participants
- Enrollment target
Study Summary
The STREAM Study is a prospective longitudinal observational outcomes study that will examine the reliability, validity and responsiveness of the PROMIS tools for clinical research following orthopaedic trauma.
Primary Outcome
The primary endpoint for this study is the reliability and construct validity of the PROMIS CAT instruments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,065 participants |
| Start Date | 2014-01 |
| Est. Completion | 2020-10 |
What the finished NCT02079714 record still lists
NCT02079714 is an observational study that tracks outcomes without assigning an intervention. Its 1,065 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02079714 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02079714 about?
NCT02079714 is a clinical study titled "Streamlining Trauma Research Evaluation With Advanced Measurement". The STREAM Study is a prospective longitudinal observational outcomes study that will examine the reliability, validity and responsiveness of the PROMIS tools for clinical research following orthopaedic trauma.
What is the current status of trial NCT02079714?
This trial is currently completed. The enrollment target is 1,065 participants. The study started on 2014-01. Estimated completion is 2020-10.
Who is sponsoring clinical trial NCT02079714?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04165798 · 1,065 participants
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
- NCT05911568 · 1,060 participants
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- NCT07140172 · 1,060 participants · NA
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia